Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Ursodeoxycholic acid

Drug Profile

Ursodeoxycholic acid

Alternative Names: Actigall; Delursan; LJDCA; UDCA; Urso; Urso 500; Urso DS; Urso Forte; Ursobilane; Ursochol; Ursodesoxycholic acid; Ursodiol; Ursolite; Ursosan

Latest Information Update: 04 Nov 2018

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Alfa Farmaceutici; sanofi-aventis
  • Developer Adare Pharmaceuticals; Allergan; Axcan Pharma; Estedi; Mitsubishi Tanabe Pharma Corporation; Novartis; Procter & Gamble Pharmaceuticals Spain; sanofi-aventis; Zambon Company SpA
  • Class Cholic acids; Gallstone therapies; Hepatoprotectants; Small molecules
  • Mechanism of Action Apoptosis inhibitors; Cholesterol inhibitors; Immunomodulators; Immunosuppressants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Cholelithiasis; Liver disorders; Primary biliary cirrhosis; Primary sclerosing cholangitis
  • No development reported Colorectal cancer; Hypercholesterolaemia; Liver transplant rejection; Non-alcoholic steatohepatitis

Most Recent Events

  • 24 Jun 2018 Biomarkers information updated
  • 10 Jun 2015 No recent reports on development identified - Phase-II for Non-alcoholic steatohepatitis in USA (PO)
  • 10 Jun 2015 No recent reports on development identified - Phase-II/III for Colorectal cancer in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top